Trust Company of Vermont’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-204
| Closed | -$25 | – | 906 |
|
|
2023
Q4 | $25 | Hold |
204
| – | – | ﹤0.01% | 798 |
|
|
2023
Q3 | $19 | Hold |
204
| – | – | ﹤0.01% | 810 |
|
|
2023
Q2 | $73 | Hold |
204
| – | – | ﹤0.01% | 819 |
|
|
2023
Q1 | $73 | Hold |
204
| – | – | ﹤0.01% | 863 |
|
|
2022
Q4 | $181 | Hold |
204
| – | – | ﹤0.01% | 844 |
|
|
2022
Q3 | $0 | Hold |
204
| – | – | ﹤0.01% | 1046 |
|
|
2022
Q2 | $0 | Buy |
+204
| New | – | ﹤0.01% | 922 |
|
|
2022
Q1 | – | Sell |
-204
| Closed | -$1K | – | 785 |
|
|
2021
Q4 | $1K | Buy |
+204
| New | +$1K | ﹤0.01% | 798 |
|
|
2021
Q3 | – | Sell |
-204
| Closed | -$2K | – | 757 |
|
|
2021
Q2 | $2K | Hold |
204
| – | – | ﹤0.01% | 759 |
|
|
2021
Q1 | $2K | Hold |
204
| – | – | ﹤0.01% | 729 |
|
|
2020
Q4 | $1K | Hold |
204
| – | – | ﹤0.01% | 750 |
|
|
2020
Q3 | $2K | Buy |
+204
| New | +$2K | ﹤0.01% | 717 |
|